Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

SCPH holding history

scPharmaceuticals Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SCPH overviewAll 13F holders of SCPHFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q1 2021
Holdings of SCPH by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−117,255−100.0%Sold outHolders
Q3 2025117,255$664.8K<0.1%−738,047−86.3%ReducedHolders
Q2 2025855,302$3.26M<0.1%+527,887+161.2%AddedHolders
Q1 2025327,415$861.1K<0.1%−709,864−68.4%ReducedHolders
Q4 20241,037,279$3.67M<0.1%+1,017,775+5,218.3%AddedHolders
Q3 202419,504$88.9K<0.1%+10,734+122.4%AddedHolders
Q2 20248,770$38.1K<0.1%−25,464−74.4%ReducedHolders
Q1 202434,234$171.9K<0.1%+4,739+16.1%AddedHolders
Q4 202329,495$184.9K<0.1%+14,963+103.0%AddedHolders
Q3 202314,532$103.5K<0.1%−2,165−13.0%ReducedHolders
Q2 202316,697$170.1K<0.1%+16,697NewHolders
Q1 20230$00.0%−3,090−100.0%Sold outHolders
Q4 20223,090$22.2K<0.1%+3,090NewHolders
Q3 20220$00.0%−2,152−100.0%Sold outHolders
Q2 20222,152$10.0K<0.1%+1,152+115.2%AddedHolders
Q1 20221,000$6.00K<0.1%−1,253−55.6%ReducedHolders
Q4 20212,253$11.0K<0.1%+1,410+167.3%AddedHolders
Q3 2021843$6.00K<0.1%+139+19.7%AddedHolders
Q2 2021704$4.00K<0.1%−1,680−70.5%ReducedHolders
Q1 20212,384$16.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.